ACAN - AmeriCann, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

AmeriCann, Inc.

1550 Wewatta Street
Denver, CO 80202
United States
303-862-9000
http://www.americann.co

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees3

Key Executives

NameTitlePayExercisedYear Born
Mr. Timothy Ryan KeoghCEO, Pres & Director144kN/A1980
Mr. Benjamin J. BartonFounder, Chief Financial & Accounting Officer and DirectorN/AN/A1965
Mr. Doug CarrVP of Sales & Bus. Devel.N/AN/AN/A
Dr. Rien Havens Ph.D.Extraction & Infused Product Advisor and Member of Advisory BoardN/AN/AN/A
Mr. Eric ForingtonGenetics & Breeding Advisor and Member of Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AmeriCann, Inc. designs, develops, and owns medical cannabis facilities to produce the medical cannabis in the United States. It partners with local businesses to serve marijuana patients in their communities. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. AmeriCann, Inc. was founded in 2010 and is based in Denver, Colorado.

Corporate Governance

AmeriCann, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.